Member Info for Hurst10

We Know you are back in the cellar,

However I seem to remember when the price was 30p and we had buyers apart from the usual suspects.who may they be ?

Pls tell us your target price , your reason for that price or your reason for being a seller.

I know you have no opinion , however you are always quick on remarks but never on buy or sell ideas.

Let us have your target price.

While I note you continue to have " No Opinion"!

Company website would be a good start.

Tempus out shopping again :

Paige’s strong foundation in pathology and AI is rooted in its proprietary dataset of almost 7 million digitized pathology slides that are clinically annotated

This allows Tempus to grow in the field of digital phathology.

Tempus' expansion in AI continues, with +40mill clinical patient records and a database of 350 petabytes of connected data.It's Tempus One and Tempus xM is being integrated into electronic health records and Biopharma pipelines.

Interesting to hear more of Avacta's JV with Tempus and its access to Tempus' datasets. Busy ESMO and investor event coming up in October.

"Getting better and better indeed "

Always interesting when a company talks about " an event " , very positive !

Dr Tap presenting for AVACTA at ESMO in October, anyone heard more about the " investor event " afterwards?

More activity in precision oncology area.

"Bayer signed a deal potentially worth $1.3 billion to partner on Kumquat Biosciences' experimental KRAS G12D inhibitor, which was cleared last month by the FDA to enter clinical testing. The agreement, announced Tuesday, is the latest move by Bayer to expand its precision oncology pipeline.

Launched in 2019 with investment from backers including OrbiMed, Lilly Asia Ventures and Roche Venture Fund, Kumquat has potential multi-billion-dollar deals in place with Eli Lilly and Takeda."

Tempus AI raises 2025 revenue guidance to $1.26B with 89.6% Q2 growth driven by genomics and data deals

Berlin not far from Zurich ! ( Novartis )

Union Pacific now confirmed buying Norfolk Southern in a $ 250bn merger.

Further consolidation to come , expect Canada National and CPKC to be next- as well BNSF and CSX.

Sector to be modernised, AI arriving and Cordel here.

Size buyers will at the opening lift offer price through 55p easily , with 1 point spread bid/offer. Next week RNS or not , volume will continue north and so will the price.

Not surprised!

Who would be on the other side of Conifer!

As discussed , note " test trades " in low units on the offer side.

Would not be surprised if you have 50p + offered for any size after 16.15

Size buyer not finished yet, but will be joined by one of his followers.

47-50 post close

Sorry if repeat .

We also have 9/9 Morgan Stanley conf

25/9 Merrill lynch

11/11 Guggenheim conf

Indeed!

The Swiss owned ESMO is hosting a conference in Berlin Oct. 17-21/10 and Dr. Tap is indeed participating and presenting.

964P - A Phase I trial of FAP-Dox (AVA6000), a Fibroblast Activation Protein (FAP)-released and tumor microenvironment (TME)-targeted doxorubicin peptide drug conjugate in patients with FAP-positive solid tumors

Presentation Number

964P

Speakers

William D. Tap (

Suspect "clumsy" prints after hours will push the price nicely to 41-3, with opening level tomorrow for any size order easily have us through 45, but off course still far from our real SOP.

Any RNS tomorrow ref AVA and FDA would be very clever indeed from a timing point of view and 2022/23 level not that far away.

Just hope we have Novartis or Llly do the licence deal now and let us have the IPO a very different level.

06.50 NY AM .

CC and management up early , keeping an eye on Conifer Management 's 4.4% holding ( Greg Alexander ) no doubt !

Quote from the Street " what truly defines Alexander is his uncanny ability to see growth opportunities others miss. It's no wonder his name has become synonymous with insight, impact and innovation) .

Agree, what is very positive purely from a trading / momentum perspective,

Is that we have size buyers moving in earlier by the day and clearly in a hurry, before the " noisy buyers steps in ", for those of you who enjoy the stock market and it's momentum ,rather than issuing rude comments , this is beginning to look like pre LFT price take off. Surely most of you ,are beginning to realise what one RNS concerning licence deal/ FDA news could and will do to the share price and current placing will have very happy share holders.

Enjoy.

As mentioned before, size buyer continuing to increase and we prints earlier in the day and outside the market.

For those of you following technical trading, you can see 12 month downwards trendline about to be broken, however today the price will again have size buyer increasing their stake and once we have early hrs in NY ( one of the best known hedge funds will continue buying and they are in a hurry ).

Pls spare us the usual nonsense from the crowd in the cellar.

To the rest of you watch the usual watch the usual MM on the bid in size very shortly.